Oral Sumatriptan Pharmacokinetics in the Migraine State

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.17, Iss.2, 1999-02, pp. : 137-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients

By Ferrari Anna

European Journal of Clinical Pharmacology, Vol. 64, Iss. 5, 2008-05 ,pp. : 489-495

Springer Publishing Company

Access to resources Recommend Favorite

Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine

By Tfelt-Hansen Peer Hougaard Anders

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 91-103

Informa Healthcare

Access to resources Recommend Favorite

Intranasal Sumatriptan: In Adolescents with Migraine

By Curran Monique P. Evans Hannah C. Wagstaff Antona J.

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 335-343

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Intranasal Sumatriptan

By Fuseau E.

Clinical Pharmacokinetics, Vol. 41, Iss. 11, 2002-01 ,pp. : 801-811

Adis International

Access to resources Recommend Favorite

Low Efficacy of Transdermal Sumatriptan in Migraine

By Tfelt-Hansen Peer

CNS Drugs, Vol. 25, Iss. 2, 2011-02 ,pp. : 171-171

Adis International

Access to resources Recommend Favorite